InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+15.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Barthelemy Nicolas, Director. Insider active across 6 companies, notably REPLIGEN CORP. Aggregated, 15 disclosures have been published. Split: 2 buys · 1 sell. Total volume traded: €577k. History available since 13 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Barthelemy Nicolas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
973 shares0Common StockSEC:0000950170-25-075705:0
1,200 shares@ US$125.4549.9% of flowCommon StockSEC:0000950170-24-073840:0
Canonical exit: 12 Sept 2024 (T+90)
701 shares0Common StockSEC:0000950170-24-062600:0
686 shares0Common StockSEC:0000899243-23-013668:0
9,082 shares@ US$23.3346.3% of flowCommon StockSEC:0001214659-22-014161:0
1,379 sharesCommon Stock, par value $0.001SEC:0001562180-22-005191:0
534 shares0Common StockSEC:0000899243-22-020279:0
8,550 shares@ US$29.2510.014% mcap100.0% of flowCommon StockSEC:0001214659-22-006826:0
Canonical exit: 9 Aug 2022 (T+90)
20,993 shares@ US$3.740.0072% mcap82.1% of flowCommon StockSEC:0001162194-22-000027:0
5,000 shares@ US$3.430.0016% mcap17.9% of flowCommon StockSEC:0001162194-22-000025:0
3,491 shares0Common StockSEC:0001214659-22-002210:0
1,285 shares@ US$128.18100.0% of flowCommon StockSEC:0000899243-21-042393:0
6,000 shares@ US$39.63100.0% of flowCommon Stock, par value $0.001SEC:0001104659-21-085908:0
10,342 shares0Common StockSEC:0001162194-21-000063:0
457 shares0Common StockSEC:0000899243-21-019710:0
15 of 15 declarations
About Barthelemy Nicolas
BARTHELEMY NICOLAS is Administrateur, Vice-Président du Développement Corporatif. He has 15 filings in total, and in the recent filings we hold, the period runs from 2021-05-17 to 2025-05-21, with EUR 378087 of buys and EUR 199260 of sells, and the modal transaction nature is Attribution. He is associated with REPLIGEN CORP, Twist Bioscience Corp, Repligen CORP, 908 Devices Inc., Standard Biotools INC. and Fluidigm CORP.
